Cingulate (CINGW) to Release Earnings on Wednesday

Cingulate (NASDAQ:CINGW) is anticipated to post its resultson Wednesday, May 13th. Analysts expect Cingulate to post earnings of ($0.52) per share for the quarter.

Cingulate Stock Performance

Shares of CINGW opened at $0.02 on Tuesday. Cingulate has a 12-month low of $0.02 and a 12-month high of $0.18. The stock’s 50-day moving average price is $0.03 and its 200 day moving average price is $0.05.

Cingulate Company Profile

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.